Increased serum chemerin concentration in patients with chronic pancreatitis

Digestive and Liver Disease

Volumn 44, Issue 5, 2012, Pages 393-397

  Adrych, Krystian ^a   Stojek, Magdalena ^a   Smoczynski, Marian ^a   Sledzinski, Tomasz ^a   Sylwia, Szrok Wojtkiewicz ^a   Swierczynski, Julian ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Inflammation; Pancreatic fibrosis; PDGF BB; TGF 1

Indexed keywords

CHEMERIN; CHEMOKINE; PLATELET DERIVED GROWTH FACTOR BB; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHRONIC PANCREATITIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; DIABETIC PATIENT; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; BODY MASS INDEX; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHEMOKINES; DIABETES MELLITUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LEPTIN; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PANCREATITIS, ALCOHOLIC; PROTO-ONCOGENE PROTEINS C-SIS; RESISTIN; SEVERITY OF ILLNESS INDEX; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84859211816     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2011.06.020     Document Type: Article

References (42)

1. Ammann R.W. A clinically based classification system for alcoholic chronic pancreatitis: summary of an international workshop on chronic pancreatitis. Pancreas 1997, 14:215-221.
2. Forsmark C.E. Chronic Pancreatitis. Gastrointestinal and liver disease 2002, 943-969. W.B. Saunders Company. M. Feldman, F.S. Friedman, M.H. Sleisenger (Eds.).
3. Sarles H. Definitions and classifications of pancreatitis. Pancreas 1991, 6:470-474.
4. DiMagno M.J., DiMagno E.P. Chronic pancreatitis. Curr Opin Gastroenterol 2005, 21:544-554.
5. Stevens T., Conwell D.L., Zuccaro G. Pathogenesis of chronic pancreatitis: an evidence-based review of past theories and recent developments. Am J Gastroenterol 2004, 99:2256-2270.
6. Toussirot E., Streit G., Wendling D. The contribution of adipose tissue and adipokines to inflammation in joint diseases. Curr Med Chem 2007, 14:1095-1100.
7. Trayhurn P., Wood I.S. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004, 92:347-355.
8. Adrych K., Smoczynski M., Goyke E., et al. Decreased serum leptin concentration in patients with chronic pancreatitis. Pancreas 2007, 34:417-422.
9. Adrych K., Smoczynski M., Stelmanska E., et al. Serum adiponectin and leptin concentrations in patients with chronic pancreatitis of alcoholic and nonalcoholic origin. Pancreas 2008, 36:120-124.
10. Adrych K., Smoczynski M., Sledzinski T., et al. Increased serum resistin concentration in patients with chronic pancreatitis: possible cause of pancreatic fibrosis. J Clin Gastroenterol 2009, 43:63-68.
11. Bozaoglu K., Bolton K., McMillan J., et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 2007, 148:4687-4694.
12. Goralski K.B., McCarthy T.C., Hanniman E.A., et al. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem 2007, 282:28175-28188.
13. Weigert J., Neumeier M., Wanninger J., et al. Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clin Endocrinol (Oxf) 2010, 72:342-348.
14. Barnea G., Strapps W., Herrada G., et al. The genetic design of signaling cascades to record receptor activation. Proc Natl Acad Sci USA 2008, 105:64-69.
15. Cash J.L., Hart R., Russ A., et al. Synthetic chemerin-derived peptides suppress inflammation through ChemR23. J Exp Med 2008, 205:767-775.
16. Zabel B.A., Nakae S., Zuniga L., et al. Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis. J Exp Med 2008, 205:2207-2220.
17. Vermi W., Riboldi E., Wittamer V., et al. Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin. J Exp Med 2005, 201:509-515.
18. Wittamer V., Franssen J.D., Vulcano M., et al. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med 2003, 198:977-985.
19. Hart R., Greaves D.R. Chemerin contributes to inflammation by promoting macrophage adhesion to VCAM-1 and fibronectin through clustering of VLA-4 and VLA-5. J Immunol 2010, 185:3728-3739.
20. Ernst M.C., Sinal C.J. Chemerin: at the crossroads of inflammation and obesity. Trends Endocrinol Metab 2010, 21:660-667.
21. Graham K.L., Zabel B.A., Loghavi S., et al. Chemokine-like receptor-1 expression by central nervous system-infiltrating leukocytes and involvement in a model of autoimmune demyelinating disease. J Immunol 2009, 183:6717-6723.
22. Parolini S., Santoro A., Marcenaro E., et al. The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 2007, 109:3625-3632.
23. Weigert J., Obermeier F., Neumeier M., et al. Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn's disease. Inflamm Bowel Dis 2010, 16:630-637.
24. Kukla M., Zwirska-Korczala K., Hartleb M., et al. Serum chemerin and vaspin in non-alcoholic fatty liver disease. Scand J Gastroenterol 2010, 45:235-242.
25. Wittamer V., Bondue B., Guillabert A., et al. Neutrophil-mediated maturation of chemerin: a link between innate and adaptive immunity. J Immunol 2005, 175:487-493.
26. Casini A., Galli A., Pignalosa P., et al. Collagen type I synthesized by pancreatic periacinar stellate cells (PSC) co-localizes with lipid peroxidation-derived aldehydes in chronic alcoholic pancreatitis. J Pathol 2000, 192:81-89.
27. Detlefsen S., Sipos B., Feyerabend B., et al. Fibrogenesis in alcoholic chronic pancreatitis: the role of tissue necrosis, macrophages, myofibroblasts and cytokines. Mod Pathol 2006, 19:1019-1026.
28. Detlefsen S., Sipos B., Zhao J., et al. Autoimmune pancreatitis: expression and cellular source of profibrotic cytokines and their receptors. Am J Surg Pathol 2008, 32:986-995.
29. Hu R., Wang Y.L., Edderkaoui M., et al. Ethanol augments PDGF-induced NADPH oxidase activity and proliferation in rat pancreatic stellate cells. Pancreatology 2007, 7:332-340.
30. Ito T. Can measurement of chemokines become useful biological and functional markers of early-stage chronic pancreatitis?. J Gastroenterol 2007, 42(Suppl 17):72-77.
31. Kordes C., Brookmann S., Haussinger D., et al. Differential and synergistic effects of platelet-derived growth factor-BB and transforming growth factor-beta1 on activated pancreatic stellate cells. Pancreas 2005, 31:156-167.
32. Masamune A., Watanabe T., Kikuta K., et al. Roles of pancreatic stellate cells in pancreatic inflammation and fibrosis. Clin Gastroenterol Hepatol 2009, 7:S48-S54.
33. Nakamura F., Shintani Y., Saotome T., et al. Effects of synthetic serine protease inhibitors on proliferation and collagen synthesis of human pancreatic periacinar fibroblast-like cells. Pancreas 2001, 22:317-325.
34. Shimizu K. Pancreatic stellate cells: molecular mechanism of pancreatic fibrosis. J Gastroenterol Hepatol 2008, 23(Suppl 1):S119-S121.
35. Talukdar R., Tandon R.K. Pancreatic stellate cells: new target in the treatment of chronic pancreatitis. J Gastroenterol Hepatol 2008, 23:34-41.
36. Zion O., Genin O., Kawada N., et al. Inhibition of transforming growth factor beta signaling by halofuginone as a modality for pancreas fibrosis prevention. Pancreas 2009, 38:427-435.
37. Adrych K. Increase in transforming growth factor β-1, laminin, and hyaluronic acid serum concentrations in advanced chronic pancreatitis. Gastroenterol Pol 2010, 17:98-102.
38. Yasuda M., Ito T., Oono T., et al. Fractalkine and TGF-beta1 levels reflect the severity of chronic pancreatitis in humans. World J Gastroenterol 2008, 14:6488-6495.
39. Homma T. Criteria for pancreatic disease diagnosis in Japan: diagnostic criteria for chronic pancreatitis. Pancreas 1998, 16:250-254.
40. Sarner M., Cotton P.B. Classification of pancreatitis. Gut 1984, 25:756-759.
41. Lehrke M., Becker A., Greif M., et al. Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. Eur J Endocrinol 2009, 161:339-344.
42. Ress C., Tschoner A., Engl J., et al. Effect of bariatric surgery on circulating chemerin levels. Eur J Clin Invest 2010, 40:277-280.